Oct 15 (Reuters) - Biogaia AB BIOGb.ST :
* BIOGAIA’S PROBIOTIC EFFECTIVE AS ADJUNCT IN PATIENTS WITH
HELICOBACTER PYLORI INFECTION
* IN A DOUBLE-BLIND, RANDOMIZED AND PLACEBO-CONTROLLED STUDY
LACTOBACILLUS REUTERI GASTRUS, IN COMBINATION WITH SO CALLED
QUADRUPLE THERAPY, WAS SHOWN TO IMPROVE ERADICATION RATE OF
INFECTIONS CAUSED BY BACTERIUM HELICOBACTER PYLORI
* SUPPLEMENTATION OF LACTOBACILLUS REUTERI GASTRUS
SIGNIFICANTLY
REDUCED SIDE-EFFECTS OF TREATMENT
Source text: https://bit.ly/2OKXgHT
Further company coverage: BIOGb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))